: Mersana Therapeutics’s stock craters after FDA halts trials of ovarian cancer treatment after patient deaths

Micron surprises investors with strong guidance, sending stock soaring

An analyst said investors were largely expecting Micron to miss on its outlook. Instead the company’s forecast topped expectations.

September 25, 2024

Bond ETF flows this year just topped annual record set in 2021

Investors are flocking to bond ETFs this year, according to State Street.

September 25, 2024

Stocks are poised for something that hasn’t happened since the days of the dot-com bubble

The S&P 500 is flirting with what would be a rare accomplishment: rising 20% or more during two consecutive calendar...

September 25, 2024

Harris sees ‘next generation of breakthroughs’ built by U.S. workers. AI, crypto could benefit.

Democratic presidential nominee Kamala Harris pledged to support cutting-edge industries and middle-class workers while touting her previously released plans, as...

September 25, 2024

Here’s who is considered middle class, as Harris and Trump fight for their votes

Though “middle class” has traditionally been shorthand for achieving a measure of financial stability, that status is precarious.

September 25, 2024

The number of millionaire college athletes has tripled. Here are the top 10 earners this year.

More college athletes are making over $1 million from NIL, and most of them play the same position

September 25, 2024

: Mersana Therapeutics’s stock craters after FDA halts trials of ovarian cancer treatment after patient deaths

About Post Author

Wall Street Today

Other

Business